rs11436

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_016505.4(ZCCHC17):​c.*280T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.553 in 453,152 control chromosomes in the GnomAD database, including 73,108 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.54 ( 23364 hom., cov: 31)
Exomes 𝑓: 0.56 ( 49744 hom. )

Consequence

ZCCHC17
NM_016505.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.911

Publications

16 publications found
Variant links:
Genes affected
ZCCHC17 (HGNC:30246): (zinc finger CCHC-type containing 17) Enables identical protein binding activity. Predicted to be involved in RNA stabilization. Predicted to be located in nucleolus. Predicted to be part of cytosolic large ribosomal subunit. [provided by Alliance of Genome Resources, Apr 2022]
FABP3 (HGNC:3557): (fatty acid binding protein 3) The intracellular fatty acid-binding proteins (FABPs) belongs to a multigene family. FABPs are divided into at least three distinct types, namely the hepatic-, intestinal- and cardiac-type. They form 14-15 kDa proteins and are thought to participate in the uptake, intracellular metabolism and/or transport of long-chain fatty acids. They may also be responsible in the modulation of cell growth and proliferation. Fatty acid-binding protein 3 gene contains four exons and its function is to arrest growth of mammary epithelial cells. This gene is a candidate tumor suppressor gene for human breast cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.618 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZCCHC17NM_016505.4 linkc.*280T>C 3_prime_UTR_variant Exon 8 of 8 ENST00000344147.10 NP_057589.2 Q9NP64-1B4DYA9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZCCHC17ENST00000344147.10 linkc.*280T>C 3_prime_UTR_variant Exon 8 of 8 1 NM_016505.4 ENSP00000343557.5 Q9NP64-1

Frequencies

GnomAD3 genomes
AF:
0.544
AC:
82650
AN:
151906
Hom.:
23365
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.462
Gnomad AMI
AF:
0.512
Gnomad AMR
AF:
0.554
Gnomad ASJ
AF:
0.641
Gnomad EAS
AF:
0.191
Gnomad SAS
AF:
0.352
Gnomad FIN
AF:
0.573
Gnomad MID
AF:
0.579
Gnomad NFE
AF:
0.623
Gnomad OTH
AF:
0.558
GnomAD4 exome
AF:
0.557
AC:
167823
AN:
301128
Hom.:
49744
Cov.:
4
AF XY:
0.552
AC XY:
85121
AN XY:
154342
show subpopulations
African (AFR)
AF:
0.461
AC:
4708
AN:
10208
American (AMR)
AF:
0.529
AC:
6351
AN:
12008
Ashkenazi Jewish (ASJ)
AF:
0.653
AC:
6397
AN:
9798
East Asian (EAS)
AF:
0.175
AC:
4055
AN:
23222
South Asian (SAS)
AF:
0.357
AC:
7055
AN:
19748
European-Finnish (FIN)
AF:
0.574
AC:
11682
AN:
20362
Middle Eastern (MID)
AF:
0.589
AC:
795
AN:
1350
European-Non Finnish (NFE)
AF:
0.625
AC:
116598
AN:
186450
Other (OTH)
AF:
0.566
AC:
10182
AN:
17982
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
3275
6550
9825
13100
16375
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
756
1512
2268
3024
3780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.544
AC:
82656
AN:
152024
Hom.:
23364
Cov.:
31
AF XY:
0.535
AC XY:
39778
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.461
AC:
19103
AN:
41440
American (AMR)
AF:
0.554
AC:
8469
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.641
AC:
2223
AN:
3468
East Asian (EAS)
AF:
0.191
AC:
990
AN:
5170
South Asian (SAS)
AF:
0.351
AC:
1687
AN:
4800
European-Finnish (FIN)
AF:
0.573
AC:
6054
AN:
10564
Middle Eastern (MID)
AF:
0.585
AC:
172
AN:
294
European-Non Finnish (NFE)
AF:
0.623
AC:
42323
AN:
67976
Other (OTH)
AF:
0.554
AC:
1169
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1862
3724
5585
7447
9309
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
704
1408
2112
2816
3520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.603
Hom.:
14208
Bravo
AF:
0.540
Asia WGS
AF:
0.283
AC:
987
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
15
DANN
Benign
0.84
PhyloP100
0.91
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11436; hg19: chr1-31837320; COSMIC: COSV60001538; COSMIC: COSV60001538; API